Ametov A S, Voronetskiĭ I B, Ol'shanskiĭ V O, Toritsyna L K, Larina I M
Med Radiol (Mosk). 1990 Feb;35(2):11-4.
Clinical and radioimmunoassay investigations performed in 162 patients with different thyroid diseases, have shown that changes in the levels of T3, T4 and TSH do not allow assessment of the nature of a tumor process. The level of calcitonin is a tumor marker of medullary carcinoma and C-cell thyroid adenomas. In the absence of pathological changes in the thyroid an increase in the level of thyroglobulin can be regarded as a tumor marker of metastatic growth of papillary and papillary-follicular cancer.
对162例患有不同甲状腺疾病的患者进行的临床和放射免疫分析研究表明，T3、T4和TSH水平的变化无法用于评估肿瘤进程的性质。降钙素水平是髓样癌和甲状腺C细胞腺瘤的肿瘤标志物。在甲状腺无病理变化的情况下，甲状腺球蛋白水平升高可被视为乳头状癌和乳头状滤泡癌转移生长的肿瘤标志物。
